ID93 + GLA-SE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ID93 + GLA-SE, covering 2023-06-01 to 2023-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults [Phase 1]